GENEVA – A groundbreaking new webinar, titled “Monetizing Existence: A Global IP Framework for Life Itself,” is set to equip participants with the essential tools to patent the most fundamental aspects of human health and existence. Organized by a consortium of leading legal firms and pharmaceutical giants, the online event promises to demystify the process of claiming ownership over biological processes, emotional states, and even the abstract concept of improvement.

“For too long, the human body and its inherent functions have been operating as open-source platforms,” stated Dr. Evelyn Thorne, head of Global IP Acquisition at PharmaCorp, in a promotional video. “Our goal is to ensure that every measurable metric of well-being, from a stable blood pressure to a fleeting moment of joy, can be properly attributed and, more importantly, licensed.”

The webinar, which boasts modules like “The Patentability of a Good Night’s Sleep” and “AI-Driven Mood Enhancement: Securing Your Emotional Algorithm,” aims to guide attendees through the intricate legal landscapes of various jurisdictions. Participants will learn how to draft claims for everything from a novel method of breathing to the unique neural pathways involved in experiencing relief.

“We’re moving beyond just drugs and devices,” explained lead presenter, Bartholomew 'Barty' Finch, a senior partner at the law firm Dewey, Cheatem & Howe. “If you can measure it, you can own it. And if you can own it, you can charge for it. We anticipate a future where simply feeling 'better' might require a micro-transaction.”

Critics argue the initiative represents a new low in the commercialization of health, but organizers maintain it's simply a necessary evolution of intellectual property law. The ultimate goal, they say, is to protect innovation, ensuring that no one can simply 'feel good' without acknowledging the proprietary systems that enable it.